Mesalamine
Who holds supplier records for Mesalamine? 30 organisations hold a current record for Mesalamine: an active US FDA Type II Drug Master File or a CEP. A further 9 organisations have only historical (inactive) DMF filings. 23 of them hold a valid EU Certificate of Suitability (22 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (18), China (4), Italy (2), Sweden (1) and 2 other countries (2); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Mesalamine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/mesalamine
Reading the evidence
- 30 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
18 of the 27 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 16 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Mesalamine expires 1 May 2030. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (30)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Mesalamine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ERREGIERRE SPAItalyCEP Company GMP cert on recordActive DMF 13883, 24889 · latest filing Apr 2011
- Zydus Lifesciences LimitedIndiaCEP Company GMP cert on recordActive DMF 22999, 27939 · latest filing Apr 2014
- Alkem Laboratories LimitedIndiaCEP Company GMP cert on recordActive DMF 33939 · latest filing Jul 2019
- CHEMI SPAItalyCEP Company GMP cert on recordActive DMF 11951 · latest filing Apr 1996
- Divis LaboratoriesIndiaCEP Company GMP cert on recordActive DMF 29998 · latest filing Nov 2015
- Iol Chemicals And Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 38338 · latest filing Oct 2023
- Ipca Laboratories LimitedIndiaCEP Company GMP cert on recordActive DMF 19261, 27245, 22617 · latest filing Jul 2013
- MAITHRI DRUGS PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 31570 · latest filing Mar 2017
- MSN LIFE SCIENCES PRIVATE LIMITEDIndiaCEP Company GMP cert on recordActive DMF 39670 · latest filing Mar 2024
- SOLARA ACTIVE PHARMA SCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 35717 · latest filing Mar 2021
- Sun Pharmaceutical Industries LimitedIndiaCEP Company GMP cert on recordActive DMF 16431, 29575, 24664 · latest filing Aug 2015
- Zhejiang Hengkang Pharmaceutical Co., Ltd.ChinaCEPActive DMF 37319 · latest filing Aug 2022
- ALP PHARM BEIJING CO LTDActive DMF 24256 · latest filing Sept 2010
- AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)IndiaActive DMF 34792 · latest filing Apr 2020
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 33910 · latest filing Jun 2019
- CTX LIFE SCIENCES PVT LTDIndiaActive DMF 29051 · latest filing Feb 2015
- DASAMI LAB PRIVATE LTDIndia Company GMP cert on recordActive DMF 37413 · latest filing Dec 2022
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 34374 · latest filing Dec 2019
- OPTIMUS DRUGS PRIVATE LTDIndiaActive DMF 35136 · latest filing Dec 2020
- SYNTESE ASCEPActive DMF 19618 · latest filing Jul 2006
- IndiaCEP
- BEC CHEMICALS PRIVATE LTDCEPInactive DMF 36257 · latest filing Feb 2023
- SwedenCEP Company GMP cert on record
- IndiaCEP
- GermanyCEP Company GMP cert on record
- Rizhao Brother Pharmaceutical Co., Ltd.ChinaCEP
- Syntese A/SDenmarkCEP Company GMP cert on record
- D. K. PHARMA CHEM PRIVATE LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- JIANGSU JUBANG PHARMACEUTICAL CO., LTD.ChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- A.H.A International Co., Ltd.ChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (22)
Certificates of Suitability on the EDQM register for Mesalamine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 41 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ZHEJIANG HENGKANG PHARMACEUTICAL CO., LTD. Sanmen | CN | CEP 2021-400 - Rev 02 Mesalazine, Pubagang site | Sept 2026 | — |
| RIZHAO BROTHER PHARMACEUTICAL CO., LTD. Rizhao | CN | CEP 2025-097 - Rev 00 Mesalazine | Aug 2026 | — |
| ALKEM LABORATORIES LIMITED Mumbai | IN | CEP 2025-327 - Rev 00 Mesalazine | Aug 2026 | — |
| CHEMI S.P.A. Patrica | IT | CEP 2003-188 - Rev 07 Mesalazine, Product codes: FV0950 (milled) and FV0943 (micronised) | Jul 2026 | Inspected Jul 2025 Italy |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | CEP 2003-267 - Rev 07 Mesalazine | Mar 2026 | — |
| D. K. PHARMA CHEM PRIVATE LIMITED Badlapur | IN | CEP 2025-039 - Rev 00 Mesalazine | Feb 2026 | Inspected Mar 2024 Sweden |
| IPCA LABORATORIES LIMITED Mumbai | IN | CEP 2006-122 - Rev 05 Mesalazine | Dec 2025 | — |
| BEC CHEMICALS PRIVATE LIMITED Mumbai | IN | CEP 2011-100 - Rev 01 Mesalazine | Jun 2025 | — |
| MSN LIFE SCIENCES PRIVATE LIMITED Bhiknoor Village | IN | CEP 2024-351 - Rev 00 Mesalazine | Mar 2025 | — |
| IOL CHEMICALS AND PHARMACEUTICALS LTD Ludhiana | IN | CEP 2023-339 - Rev 00 Mesalazine | Jan 2025 | — |
| ZYDUS LIFESCIENCES LIMITED Vadodara | IN | CEP 2024-395 - Rev 00 Mesalazine, Process-I | Nov 2024 | — |
| Syntese A/S Hvidovre | DK | CEP 2004-056 - Rev 06 Mesalazine | Mar 2024 | Inspected Feb 2026 Denmark |
| PHARMAZELL GMBH Raubling | DE | CEP 2003-203 - Rev 03 Mesalazine | Nov 2023 | Inspected Jun 2025 Germany |
| MAITHRI DRUGS PRIVATE LIMITED Bonthapally Village | IN | R1-CEP 2017-116 - Rev 00 Mesalazine | Apr 2023 | — |
| SOLARA ACTIVE PHARMA SCIENCES LIMITED Chennai | IN | R0-CEP 2021-338 - Rev 00 Mesalazine | Jan 2023 | — |
| DIVI'S LABORATORIES LIMITED Hyderabad | IN | R1-CEP 2016-050 - Rev 01 Mesalazine | Nov 2022 | — |
| AMOLI ORGANICS PRIVATE LIMITED Mumbai | IN | R0-CEP 2020-167 - Rev 00 Mesalazine | Nov 2021 | — |
| CAMBREX KARLSKOGA AB Karlskoga | SE | R1-CEP 2003-071 - Rev 03 Mesalazine, Grade S | Jun 2021 | — |
| CTX LIFESCIENCES PVT. LIMITED Surat | IN | R1-CEP 2015-152 - Rev 00 Mesalazine | Jun 2021 | — |
| ERREGIERRE S.P.A. San Paolo D'Argon | IT | R1-CEP 2004-049 - Rev 04 Mesalazine | Oct 2019 | — |
| JIANGSU JUBANG PHARMACEUTICAL CO., LTD. Liyang | CN | R1-CEP 2012-162 - Rev 00 Mesalazine | Mar 2019 | — |
| A.H.A International Co., Ltd. Hefei | CN | R1-CEP 2010-149 - Rev 00 Mesalazine | Aug 2015 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (9)
Organisations whose Type II DMFs for Mesalamine are no longer active. These show a past filing, not current supply.
Show all 9 historical records
- India · Inactive DMF 31887 · filed Jul 2017
- SIGNA SA DE CVInactive DMF 29676 · filed Jan 2016
- India · Inactive DMF 21514 · filed Mar 2008
- LUPIN MANUFACTURING SOLUTIONS LTDInactive DMF 21489 · filed Mar 2008
- India · Inactive DMF 18387 · filed May 2005
- United States · Inactive DMF 18054 · filed Feb 2005
- Italy · Inactive DMF 11807 · filed Jan 1996
- PLIVA CROATIA LTDInactive DMF 10645 · filed Jan 1993
- CILAG CHEMIE AGInactive DMF 6605 · filed Sept 1986
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (39 listed products contain Mesalamine). The latest listed patent expires 1 May 2030. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Mesalamine is an anti-inflammatory drug used to treat inflammatory bowel diseases, such as ulcerative colitis. It works by inhibiting the production of substances in the lining of the colon that cause inflammation.
Chemical identity
- IUPAC name
- 5-amino-2-hydroxybenzoic acid
- Canonical SMILES
- C1=CC(=C(C=C1N)C(=O)O)O
- InChIKey
- KBOPZPXVLCULAV-UHFFFAOYSA-N
- Synonyms
- apriso, asacol, benzoic acid, 5-amino-2-hydroxy-, canasa, fisalamine, iialda, lialda, max-002, mesalazine, nsc-38877, pentasa, rowasa
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Aminosalicylate
- Chemical structure
- Aminosalicylic Acids
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Mesalamine?
30 organisations hold an active US FDA Type II Drug Master File or a CEP for Mesalamine: ERREGIERRE SPA (Italy), Zydus Lifesciences Limited (India), Alkem Laboratories Limited (India), CHEMI SPA (Italy), Divis Laboratories (India), Iol Chemicals And Pharmaceuticals Limited (India), Ipca Laboratories Limited (India) and MAITHRI DRUGS PRIVATE LTD (India), and 22 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Mesalamine Drug Master Files are active?
ERREGIERRE SPA (DMF 13883, 24889), Zydus Lifesciences Limited (DMF 22999, 27939), Alkem Laboratories Limited (DMF 33939), CHEMI SPA (DMF 11951), Divis Laboratories (DMF 29998), Iol Chemicals And Pharmaceuticals Limited (DMF 38338), Ipca Laboratories Limited (DMF 19261, 27245) and MAITHRI DRUGS PRIVATE LTD (DMF 31570) and 12 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Mesalamine records mean?
9 organisations have only inactive Type II DMFs for Mesalamine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Mesalamine have a European Certificate of Suitability?
Yes. 23 organisations hold a valid CEP for Mesalamine on the EDQM register, including ZHEJIANG HENGKANG PHARMACEUTICAL CO., LTD. Sanmen (CN), RIZHAO BROTHER PHARMACEUTICAL CO., LTD. Rizhao (CN), ALKEM LABORATORIES LIMITED Mumbai (IN), CHEMI S.P.A. Patrica (IT), SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN) and D. K. PHARMA CHEM PRIVATE LIMITED Badlapur (IN) and 16 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Mesalamine?
Yes. The latest patent listed for an approved US product containing Mesalamine expires 1 May 2030, across 39 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Mesalamine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Mesalamine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.